Featured Content

R&D
JP Morgan 2024 – Sam Deutsch

JP Morgan 2024 – Sam Deutsch

In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica

Newsletters and Deep Dive
digital magazine

Latest News

Views & Analysis

R&D
diagnostics device for multiple conditions

In search of the fabled tricorder

When two or more people from the world of medical technology meet, talk inevitably turns to the ongoing, yet elusive, search for an industry-standard, multi-disciplinary diagnostic device –

Deep Dive

White Papers & Webinar

live
Sales & Marketing
Upscaling your brand strategy game with new ways of planning
Sponsored

Take pharma brand planning to the next level in 2024

Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment

on demand
Digital
How AI is supercharging clinical trials
Sponsored

How AI is supercharging clinical trials

Artificial intelligence (AI) and machine learning are here to stay, so it’s crucial to understand how they can be used to the best effect in the evolving world of clinical trials.<

Podcasts & Video

R&D
JP Morgan 2024 – Sam Deutsch

JP Morgan 2024 – Sam Deutsch

In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica

Partner Content